✦ LIBER ✦

Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma

✍ Scribed by Sundar Jagannath; Brian G. M. Durie; Jeffrey Lee Wolf; Elber S. Camacho; David Irwin; Jose Lutzky; Marti McKinley; Phyllis Potts; Afshin Eli Gabayan; Amitabha Mazumder; John Crowley; Robert Vescio

Book ID: 108676407
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 209 KB
Volume: 146
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2009.07803.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 study of two sequential three-dr

Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma

✍ William I. Bensinger; Sundar Jagannath; Robert Vescio; Elber Camacho; Jeffrey Wo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Extended follow-up of outcome measures i

Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin

✍ Suzanne E. Biehn; Dominic T. Moore; Peter M. Voorhees; Reynaldo A. Garcia; Mary 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 128 KB

A phase I study of bortezomib in combina

A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma

✍ Yasushi Takamatsu; Kazutaka Sunami; Hiroyuki Hata; Koji Nagafuji; Ilseung Choi; 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 167 KB

Bortezomib, doxorubicin, and dexamethaso

Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety

✍ Sung Sook Lee; Cheolwon Suh; Bong-Seog Kim; Jooseop Chung; Young-Don Joo; Hun-Mo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 151 KB

Bortezomib in combination with epirubici

Bortezomib in combination with epirubicin, dexamethasone and thalidomide is a highly effective regimen in the treatment of multiple myeloma: a single-center experience

✍ Shuqing Lü; Jianmin Wang; Xiaoqian Xu; Xiong Ni; Chongmei Huang; Huiying Qiu; Xi 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 158 KB

Extended follow-up of a phase II trial i

Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma: : Final time-to-event results from the SUMMIT trial

✍ Paul G. Richardson; Bart Barlogie; James Berenson; Seema Singhal; Sundar Jaganna 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views